With the recent publication of the European Commission proposal for a new pharmaceutical legislation, this Conference will be a timely and unmissable opportunity for attendees to be informed about the new legislative proposal and its impact on future day-to-day regulatory operations and on the long-term implications for the off-patent sector in the coming decades.
The conference will bring together key stakeholders, including leading regulators, industry experts, and European institution officials, to engage in discussions and debates on the regulatory challenges and opportunities that lie ahead.
